Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 7, 2010, Pages 850-859

  Adelstein, Evan C ^a   Shalaby, Alaa ^b   Saba, Samir ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cardiac resynchronization; heart failure; implantable cardioverter defibrillator; renal insufficiency

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE;

AGED; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PENNSYLVANIA; PREVALENCE; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77954381137     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02705.x     Document Type: Article

References (26)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
2. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549. (Pubitemid 40517094)
3. Abraham WT, Fisher AWG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 346 : 1845 1853.
4. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure. J Am Coll Cardiol 2006 47 : 1987 1996.
5. Boerrigter G, Costello-Boerrigter LC, Abraham WT, St. John Sutton MG, Heublein DM, Kruger KM, Hill MR, et al. Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Cardiac Fail 2008 14 : 539 546.
6. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008 52 : 1527 1539.
7. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006 296 : 1377 1384.
8. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation 2004 109 : 1004 1009.
9. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
10. Lin G, Brady PA. Chronic renal insufficiency is associated with worse mortality in patients undergoing prophylactic defibrillator implantation. J Card Fail 2007 13 : S162.
11. Shalaby A, El-Saed A, Voigt A, Albany C, Saba S. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2008 31 : 575 579.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
13. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002 39 : S1 S266.
14. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, Gatewood RP. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987 75 : 175 183.
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989 2 : 358 367.
16. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
17. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial. J Card Fail 2000 6 : 276 285.
18. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Klein W, et al. The CARE-HF study (Cardiac Resynchronization in Heart Failure study): Rationale, design, and end-points. Eur J Card Fail 2001 3 : 481 489.
19. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006 114 : 2766 2772.
20. Fung JWH, Szeto CC, Chan JYS, Zhang Q, Chan HCK, Yip GWK, Yu CM. Prognostic value of renal function in patients with cardiac resynchronization therapy. Int J Cardiol 2007 122 : 10 16.
21. Schrier RW. Role of diminished renal function in cardiovascular mortality: Marker or pathogenetic factor? J Am Coll Cardiol 2006 47 : 1 8.
22. Inage T, Yoshida T, Hiraki T, Ohe M, Takeuchi T, Nagamoto Y, Fukuda Y, et al. Chronic cardiac resynchronization therapy reverses cardiac remodeling and improves invasive hemodynamics of patients with severe heart failure on optimal medical treatment. Europace 2008 10 : 379 383.
23. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000 102 : 3053 3059.
24. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, et al. Effect of oral milrinone on mortality in severe heart failure. The PROMISE Study Research Group. N Engl J Med 1991 325 : 1468 1475.
25. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009 53 : 589 596.
26. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009 53 : 582 588.